Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses

被引:5
作者
Blazevic, V
Mac Trubey, C
Shearer, GM
机构
[1] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Intramural Res Support Program, Frederick, MD USA
关键词
costimulatory molecules; cytokines; T lymphocytes; human;
D O I
10.1023/A:1010987426835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study analyzes the role of CD28-B7-mediated costimulation during in vitro human peripheral blood memory T cell activation by influenza A virus. Inhibition studies using the B7-binding fusion protein CTLA41g and antibodies against CD80 and CD86 demonstrate that CTLA41g and anti-CD86 inhibited influenza-specific T cell proliferation, interleukin (IL)-2 and interferon (IFN)-gamma production, and generation of influenza-specific CD8+ CTL. The production of IL-10 and IL-18, which are known to modulate T cell immune responses, were not affected by blocking the CD28-B7 costimulatory pathway. Inhibition of diverse influenza-specific T cell functions could be reversed by the addition of exogenous IL-2 or IL-12 but not by the addition of IFN-gamma or IL-18. Although IL-2 is known to overcome CD28-B7 costimulatory requirements, this is the first report showing that exogenous IL-12 is able to bypass CD28-B7 costimulatory blockade induced by CTLA41g in vitro. The induction of IFN-gamma production with the recently described IFN-gamma inducing cytokine IL-18 was not detected. In conclusion, these results demonstrate that CD86 represents a major costimulatory signal for the activation of resting peripheral blood memory T cells with recall antigens. These observations may have important implications for the development of immunotherapeutic strategies in diverse immunodeficiency diseases as well as in tumor immunotherapy.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 45 条
[1]   THE YIN AND YANG OF T-CELL COSTIMULATION [J].
ALLISON, JP ;
KRUMMEL, MF .
SCIENCE, 1995, 270 (5238) :932-933
[2]  
Barker E, 1997, J IMMUNOL, V159, P5123
[3]  
BIDDISON WE, 1979, J IMMUNOL, V122, P660
[4]  
Blair PJ, 1998, J IMMUNOL, V160, P12
[5]   Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism [J].
Blazevic, V ;
Pinto, LA ;
Mac Trubey, C ;
Shearer, GM .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (06) :817-824
[6]  
Bluestone JA, 1996, CLIN TRANSPLANT, V10, P104
[7]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[8]  
Caruso A, 1998, EUR J IMMUNOL, V28, P3630, DOI 10.1002/(SICI)1521-4141(199811)28:11<3630::AID-IMMU3630>3.0.CO
[9]  
2-6
[10]  
Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO